Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Buzaid

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
AMB : Revista Da Associacao Medica Brasileira|May 1, 1985
[Takayasu's arteritis: study of 16 cases, clinical, laboratory aspects and review of the literature]A C Buzaid, R Milani Júnior, I Calich, et al.
Journal of Skin Cancer|July 21, 2021
Retrospective Analysis of Rechallenge with Ipilimumab in Patients with Metastatic MelanomaA A Formozo, J R Gomes, R A Schmerling, et al.
American Journal of Clinical Oncology|February 1, 1997
Treatment of advanced pancreatic adenocarcinoma with 5-FU, leucovorin, interferon-alpha-2b, and cisplatinJ R Sporn, A C Buzaid, D Slater, et al.
Cancer Surveys|January 1, 1996
Detection of melanoma cells in peripheral blood using reverse transcription polymerase chain reaction assay for tyrosinase mRNAF A Jung, A C Buzaid, K V Woods, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Role of computed tomography in the staging of patients with local-regional metastases of melanomaA C Buzaid, L Tinoco, M I Ross, et al.
Melanoma Research|June 1, 1996
Interleukin-6 production and secretion in human melanoma cell lines: regulation by interleukin-1G M Francis, E G Krohn, K V Woods, et al.
Oncology Reports|July 30, 1999
Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapyJ A Ellerhorst, A Bedikian, S Ring, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanomaS S Legha, S Ring, O Eton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alphaS S Legha, S Ring, A Bedikian, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 16, 2007
Electrochemical therapy to treat cancer (in vivo treatment)M Telló, L Oliveira, O Parise, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
AMB : Revista Da Associacao Medica Brasileira|May 1, 1985
[Takayasu's arteritis: study of 16 cases, clinical, laboratory aspects and review of the literature]A C Buzaid, R Milani Júnior, I Calich, et al.
Journal of Skin Cancer|July 21, 2021
Retrospective Analysis of Rechallenge with Ipilimumab in Patients with Metastatic MelanomaA A Formozo, J R Gomes, R A Schmerling, et al.
American Journal of Clinical Oncology|February 1, 1997
Treatment of advanced pancreatic adenocarcinoma with 5-FU, leucovorin, interferon-alpha-2b, and cisplatinJ R Sporn, A C Buzaid, D Slater, et al.
Cancer Surveys|January 1, 1996
Detection of melanoma cells in peripheral blood using reverse transcription polymerase chain reaction assay for tyrosinase mRNAF A Jung, A C Buzaid, K V Woods, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Role of computed tomography in the staging of patients with local-regional metastases of melanomaA C Buzaid, L Tinoco, M I Ross, et al.
Melanoma Research|June 1, 1996
Interleukin-6 production and secretion in human melanoma cell lines: regulation by interleukin-1G M Francis, E G Krohn, K V Woods, et al.
Oncology Reports|July 30, 1999
Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapyJ A Ellerhorst, A Bedikian, S Ring, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanomaS S Legha, S Ring, O Eton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alphaS S Legha, S Ring, A Bedikian, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 16, 2007
Electrochemical therapy to treat cancer (in vivo treatment)M Telló, L Oliveira, O Parise, et al.
Pageof 8